Peptide
Also called: peptide therapy, peptides, what is a peptide
Clinical reviewer: Jacob Moore, MD · Last checked September 16, 2026
What is a peptide?
Peptide is a short chain of amino acids, which FDA defines as 40 or fewer. Longer chains are proteins. Peptides sit between small-molecule drugs and large proteins, and many approved medications are peptides. Because a peptide is not a biological product, it is regulated as a drug and must be FDA-approved before it can be marketed.
How does FDA define a peptide?
By length. FDA treats any amino-acid polymer of 40 or fewer amino acids as a peptide, and any chain longer than 40 as a protein [1]. That line matters legally: a protein is a biological product, while a peptide is not, so a peptide is regulated as a drug under the Federal Food, Drug, and Cosmetic Act [1][2]. A new peptide drug must be approved under section 505 before it can be marketed, like any other drug [2].
What is the difference between approved and unapproved peptides?
Approved peptide drugs have been through FDA review of both safety and effectiveness. A 2026 review in Sports Medicine describes a parallel "gray market" of unapproved peptides sold direct to patients, operating largely outside regulatory oversight [3]. Many of these show tissue-repair or metabolic effects in animal models, but rigorous human safety data are scarce and the authors warn of potential for serious harm [3]. Examples on that unapproved list include BPC-157 and TB-500 [3].
Is peptide therapy legal?
It depends on the peptide and how it reaches you. An FDA-approved peptide prescribed by a licensed clinician is a normal prescription. A compounded peptide is legal only within the compounding rules, and products sold as research use only are not lawful drugs for human use.
Related terms
Sources
- FDA — The "Deemed To Be a License" Provision of the BPCI Act, Questions and Answers (Guidance for Industry, March 2020)
- FDA — Clinical Pharmacology Considerations for Peptide Drug Products (Draft Guidance, December 2023)
- Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Medicine, 2026.
This entry is for education and is not medical advice. Talk with a licensed clinician about your own situation before starting, stopping, or changing any treatment.
